Tradestie Institutional Equity Comparison Engine

MXCT vs OABI โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MXCT Overall Edge

MXCT Captures Institutional Edge (2โ€“1 Pillars ยท 2โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MaxCyte, Inc. Common Stock (MXCT) driven by superior Growth & Margin, Options & Structure while OABI counters with relative strength in Momentum & Technical. Fundamentally, MXCT trades at N/M Forward P/E with -85.5% operating margin (+48.7% YoY revenue) versus OABI at N/M Forward P/E and -92.9% operating margin (+78.3% YoY). In options structure, MXCT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against OABI sits in CONSOLIDATION (14th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
MXCT N/M vs OABI N/M Fwd P/E
Growth & Margin Winner MXCT
Op Margin -85.5% vs -92.9% ยท YoY +48.7% vs +78.3%
Momentum & Technical Winner OABI
1Y -19.4% vs +182.4% ยท 52W Pos 63% vs 81%
Options & Structure Winner MXCT
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (14th %ile IV)
MXCT NASDAQ
MaxCyte, Inc. Common Stock
Services-Commercial Physical & Biological Research
$1.37
+7.03% 1D
Market Cap $132.2M
1M Return -4.2%
1Y Return -19.41%
Forward P/E N/M
Unified AI Score
41.7 / 100 SELL
Tech 46.0 Fund 52.0 Flow 62.0 Mom 50.0
OABI NASDAQ
OmniAb, Inc. Common Stock
Services-Commercial Physical & Biological Research
$4.66
-7.36% 1D
Market Cap $733.7M
1M Return -2.51%
1Y Return +182.42%
Forward P/E N/M
Unified AI Score
45.5 / 100 HOLD
Tech 15.0 Fund 40.0 Flow 58.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MXCT -19.41% OABI +182.42% Spread: +201.83 pp (OABI Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period MXCT Revenue OABI Revenue MXCT Op. Margin OABI Op. Margin Margin Edge
FY2019 $10M N/A -93.7% N/A MXCT
FY2020 $20M N/A -71.6% N/A MXCT
FY2021 $20M $30M -84.3% -102.5% MXCT
FY2022 $30M $60M -95.2% -45.1% OABI
FY2023 $20M $30M -247.7% -203.2% OABI
FY2024 $20M $30M -230.5% -282.3% MXCT
FY2025 $20M $20M -247.6% -369.5% MXCT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MXCT (2) vs OABI (6)
Institutional Metric MXCT OABI Criterion Row Winner
Market Capitalization Scale $132.2M $733.7M Larger Scale OABI
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +48.7% +78.3% Higher Growth OABI
Operating Margin (TTM) Profitability -85.5% -92.9% Higher Margin MXCT
Net Profit Margin Profitability -81.4% -108.1% Higher Margin MXCT
Return on Equity (ROE) Capital Efficiency -16.9% -16.5% Higher ROE OABI
52-Week Range Position Momentum 63% ($1โ€“$2) 81% ($1โ€“$5) Stronger Trend OABI
Beta / 30D Volatility Risk Regime 1.19ฮฒ ยท 96% Vol 1.24ฮฒ ยท 60% Vol Lower Realized Risk OABI
Unified Institutional Score Composite Signal 41.7 / 100 (SELL) 45.5 / 100 (HOLD) Higher Composite OABI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MXCT vs OABI Buy Guide
MXCT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MXCT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
OABI CONSOLIDATION
17d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 14th %ile
IV Regime Compressed (<25th %ile)
Live OABI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MXCT nor OABI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.